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Phospholipase C in Dictyostelium discoideum
Identification of stimulatory and Inhibitory surface receptors and G-proteins
Anthony A. BOMINAAR* and Peter J. M. VAN HAASTERT
Department of Biochemistry, University of Groningen, Nijenborgh 4, 9747 AG Groningen, The Netherlands
A combined biochemical and genetic approach was used to show
that phospholipase C in the cellular slime mould Dictyostelium is
under dual regulation by the chemoattractant cyclic AMP
(cAMP). This dual regulation involves stimulatory and inhibitory
surface receptors and G-proteins. In wild-type cells both cAMP
and guanosine 5'-[y-thio]triphosphate (GTP[S]) stimulated
phospholipase C. In contrast, mutantfgdA, lacking the G-protein
a-subunit Ga2, showed no stimulation by either cAMP or
GTP[S], indicating that Ga2 is the stimulatory G-protein. In
mutant fgd C cAMP did not stimulate phospholipase C, but
stimulation by GTP[S] was normal, suggesting that the defect in
this mutant is upstream of the stimulatory Ga2. Inhibition of
INTRODUCTION
In many organisms, signal transduction via Ins(1,4,5)P, plays a
crucial role in Ca2+ homoeostasis and related cellular responses
ranging from chemotaxis to cell proliferation (for reviews see
[1,2]). In the cellular slime mould Dictyostelium discoideum the
transition from the unicellular vegetative stage to the devel-
opmental multicellular stage is mediated by chemotaxis towards
extracellular cyclic AMP (cAMP) [3]. After starvation, cells
develop a cAMP-signal-transducing system [4,5]. In response to
cAMP, multiple second-messenger systems are activated, in-
cluding adenylate and guanylate cyclase [5-9]. Apart from these
two enzymes generating cAMP and cyclic GMP, Dictyostelium
also shows an increase in cellular levels of Ins(1,4,5)PJ, in response
to the chemoattractant cAMP [10-13].
Mutants ofthe frigid class (fgd) are defective in cAMP-induced
development [14]. Previous work showed that Ins(1,4,5)P3 sig-
nalling is impaired in mutants fgd A and fgd C [15-17]. In the
mutant fgd A nearly all signal transduction is blocked, due to a
deletion in one of the a-subunits of G-proteins, Ga2 [15,18]. The
primary defect in the mutantfgdC is still unknown. This mutant
shows relatively normal cAMP and cyclic GMP responses but no
increase in Ins(1,4,5)P3 levels after stimulation of cells with
cAMP. At the same time this mutant needs 100-fold higher
concentrations ofcAMP for a chemotactic response as compared
with wild-type cells [16].
By using analogues of cAMP, it was shown not only that
Ins(1,4,5)P3 levels may increase upon stimulation, but that a
decrease of Ins(1,4,5)P3 levels is also possible [19]. Analogues
which were shown previously to act as partial antagonists [20]
induced inhibition of Ins(1,4,5)P, production in vivo. This
inhibition of Ins(1,4,5)P3 production correlates well with the
observed antagonism for chemotaxis. The data described above
indicate that, apart from a simulatory pathway, phospholipase C
activity in Dictyostelium is regulated by an inhibitory pathway as
phospholipase C was achieved in wild-type cells by the partial
antagonist 3'-deoxy-3'-aminoadenosine 3',5'-phosphate (3'NH-
cAMP). This inhibition was no longer observed in transformed
cell lines lacking either the surface cAMP receptor cARl or the
G-protein a-subunit Gal; in these cells the agonist cAMP still
activated phospholipase C. These results indicate that Dictyo-
stelium phospholipase C is regulated via a stimulatory and an
inhibitory pathway. The inhibitory pathway is composed of the
surface receptor cARl and the G-protein Gl. The stimulatory
pathway consists of an unknown cAMP receptor (possibly the
fgd C gene product) and the G-protein G2.
well. Recently several reports suggest such a dual regulation of
phospholipase C in other organisms [21-27].
To date, four different genes coding for cAMP surface
receptors and eight different genes coding for G-protein a-
subunits have been cloned in Dictyostelium [28-32]. By using
homologous recombination, cell lines were made lacking the
surface receptor cARl or the G-protein a-subunits Gal, Ga2 or
Ga3 [33,34]; M. Pupillo and P. N. Devreotes, unpublished
work). These transformed cells, together with signal-transduction
mutants and cAMP antagonists, provide a powerful tool for
investigating the function of receptors and G-proteins in specific
parts of the transmembrane signal-transduction pathways. In
the preceding paper [35] a receptor- and G-protein-sensitive
phospholipase C activity in Dictyostelium discoideum was
characterized. Here we used a combined approach of mutants,
transformants and cAMP analogues to identify the receptors and




[3H]Ins(1,4,5)P3 (20-60,Ci/mmol) was obtained from Amer-
sham International. Guanosine 5'-[a-thio]triphosphate (GTP[S])
was obtained from Boehringer Mannheim. cAMP, EGTA and
Hepes were from Sigma. 3'-Deoxy-3'-aminoadenosine 3',5'-
monophosphate (3'-NH-cAMP) was kindly given by Dr. B.
Jastorff (University of Bremen, Germany); all other chemicals
used were of at least analytical grade.
Cells and cell culture
Cell strains AX3, JH130, JH 131, HPS400, G3T2, 1A3 and 0 280
were grown in axenic medium HG-5, which is an adapted form
of the HL-5 medium [36] containing 10 g/l instead of 16 g/l
Abbreviations used: cAMP, cyclic AMP; GTP[S], guanosine 5'-[y-thio]triphosphate; 3'NH-cAMP, 3'-deoxy-3'-aminoadenosine 3',5'-monophosphate.
* To whom reprint requests should be addressed.
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glucose. Cell strains NC-4, HC-85, HC-317, XP-55 and HC-6
were grown in co-culture with Klebsiella aerogenes on solid
medium containing 3.3 g/l glucose, 3.3 g/l peptone and 10 mM
Na/K phosphate buffer, pH 6.5. Axenically grown strains were
harvested in the late-exponential phase, and bacterial-grown
strains just before clearing of the bacterial lawn. Cells were
starved for 4 h by shaking in Na/K phosphate buffer, pH 6.5, to
acquire aggregation competence.
ins(1,4,5)P3 production in vivo
Aggregation-competent cells were harvested, washed once in
40 mM Hepes/NaOH, pH 6.5, and resuspended in this buffer at
5 x 107 cells/ml. Before starting the experiment, cells were aerated
for 10 min, and aeration was continued during the experiment.
Stimulation of cells was performed by adding 270,l of cell
suspension to 30,l of 10-times-concentrated stimulus. Subse-
quently 50 ,u1 samples were withdrawn at the indicated times and
quenched by addition of an equal volume of 3.5 % HCl04. The
zero-time points were obtained by taking 45 ,ul of cell suspension
and adding this to 50 #1 of 3.5 % HCl04 plus 5 ,ul of stimulus just
before the stimulation of the other cells.
Phospholipase C activity in vitro
Phospholipase C activity was determined as described in the
preceding paper [35]. In short, cells were harvested and resus-
pended as described above. Portions of cells were stimulated with
cAMP and lysed in the presence of 5.9 mM EDTA; 10 s after
lysis, part of the sample was quenched with an equal volume of
3.5 % HCl04 and the other part was adjusted to 10 #uM free Ca2l
by addition of 5.9 mM CaCl2 and incubated for another 20 s
before being quenched. Ins(1,4,5)P3 levels were determined in
samples neutralized with KHCO3, by using an isotope-dilution
assay as described previously [13,37]. Phospholipase C activity is
defined as the amount of Ins(1,4,5)P3 produced during the 20 s
incubation with Ca2 .
Ins(1,4,5)P3 phosphatase activity was measured as described in
the preceding manuscript [35].
RESULTS
Mutants fgd A and fgd C defective in phospholipase C stimulation
Stimulation offgd C and fgd A cells with the chemoattractant
cAMP in vivo does not elicit an increase in Ins(1,4,5)P3 levels; in
fact, cAMP induces a small decrease in both strains (Figure la).
To investigate the nature of the defect in these mutants, the
activation of phospholipase C by cAMP and GTP[S] was
investigated in vitro. Mutant cells were stimulated with cAMP
and phospholipase C activity was determined. Basal phospho-
lipase C activity in these mutants is not significantly different
from the activity of wild-type cells. Whereas cAMP stimulates
phospholipase C activity about 2-fold in wild-type cells, addition
of cAMP to these mutants leads to the inhibition of basal
phospholipase C activity (Figure lb); activities relative to
unstimulated activity are: wild-type 216 + 63 %,fgdA 71 + 37 %,
fgd C 42 + 20%.
The non-hydrolysable GTP analogue GTP[S] was used to
activate G-proteins. In wild-type cells GTP[S] stimulates
phospholipase C about 2-fold [35]. Figure l(b) demonstrates
that GTP[S] does not stimulate phospholipase C in fgd A cells,
suggesting that the Gx2 protein, which is impaired in fgd A, is
responsible for activation of phospholipase C. In contrast,fgd C
shows a wild-type response towards GTP[S] in vitro, indicating
that G-protein/phospholipase C coupling is intact in this mutant
(Figure Ib). Since receptor-stimulated activity is lost, this suggests
that the defect in fgd C is upstream from the G-protein. All
current models for G-protein-based signal transduction have
only one component upstream of the G-protein, i.e. the receptor;
fgd C may be a stimulatory receptor mutant.
Several observations, including the inhibition ofphospholipase
C by cAMP infgdA andfgd C (Figure 1), suggest the presence
of another receptor- and G-protein-based mechanism involved
in the decrease of phospholipase C activity.
Inhibition of phospholipase C by the cAMP analogue 3'NH-cAMP
The hypothesis for a G-protein-coupled inhibitory pathway of



























NC-4 fgdA fgd C
Figure 1 Ins(1,4,5)P3 levels and phospholipase C activity In fgd A and fgd
C mutant strains
(a) Ins(1,4,5)P3 response after stimulation of cells with 0.1 tiM cAMP: 0, wild-type cells; *,
fgd A strain HC85; *, fgd C strain HC 317. Data are presented as means+S.E.M. of 4
independent experiments in triplicate. (b) Phospholipase C activity in vitro after stimulation of
cells in vivo with 1 4aM cAMP or in vitro with 10,uM GTP[S]. Data are expressed as
means+ S.E.M. of 3 independent experiments in duplicate: significant differences from control
are shown by *P < 0.05 and **P < 0.01.
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Figure 2 Effect of the partial antagonist 3'NH-cAMP on lns(1,4,5)P3 levels
in vivo and phospholipase C activity in vitro
(a) Time course of Ins(1,4,5)P3 levels after stimulation of wild-type cells with 1 PM cAMP (0)
or 10 FM 3'NH-cAMP (U). Data are expressed as means+S.E.M. of 3 independent
experiments in triplicate. (b) Phospholipase C activity in vitro after stimulation of cells in vivo
with 1 FM cAMP or with 10 FM 3'NH-cAMP.
analogues such as 3'NH-cAMP induce a decrease in Ins(1,4,5)P3
levels in vivo. In Figure 2 the effect of 3'NH-cAMP both on
Ins(1,4,5)P3 levels in vivo as well as on phospholipase C activity
in vitro is shown. In vivo the analogue induces a rapid decrease in
Ins(1,4,5)P3 levels, with hardly any Ins(1,4,5)P3 remaining at
30 s after stimulation (Figure 2a). In vitro a strong inhibition of
phospholipase C activity is observed after stimulation with the
analogue. Basal phospholipase C activity is decreased to 30 % of
that in untreated cells (Figure 2b).
Apparently 3'NH-cAMP activates an inhibitory pathway of
phospholipase C. Although no reports are available to date on
G-protein-coupled stimulation of Ins(1,4,5)P3 phosphatases, this
possibility could not be excluded as a partial source for the
observed decrease in Ins(1,4,5)P3 in vivo. Therefore Ins(1,4,5)P3
phosphatase activity after stimulation of cells with 3'NH-cAMP
was measured. No difference in Ins(1,4,5)P3 phosphatase activity
in lysates of untreated cells compared with 3'NH-cAMP-treated
cells was observed (results not shown).
Identfflcation of the receptors and G-proteins Involved in
phospholipase C Inhibitlon
Since 3'NH-cAMP was recognized as a selective activator of the
inhibitory pathway, it was used to identify the receptor and G-
protein that mediate inhibition of phospholipase C activity. Cell
lines with a gene disruption of one of the possible components
were tested for activation and inhibition of phospholipase C in
response to cAMP or the analogue 3'NH-cAMP. To date, eight
different Ga subunits have been cloned, and four different cAMP
receptors [28-32]. By using homologous recombination, cell lines
have been created carrying three different Ga-gene disruptions,
i.e. Gal, Gac2 (=fgd A) and Ga3, and a receptor-gene disruption











Figure 3 Effect of the partIal antagonist 3'NH-cAMP on Ins(1,4,5)P3 1eve1s
In the Gal-null cell line JH131
Cells were stimulated with 10 ,uM 3'NH-cAMP, and lns(1,4,5)P3 levels were determined. 0,
Control cells (JH130); *, Gacl-null cells (JH131). Data are expressed as means+S.E.M. of
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Figure 4 Effect of the partial antagonist 3'NH-cAMP on lns(1,4,5)P3 levels
In the cARI-null cell line 0280
Cells were stimulated with 10 FuM 3'NH-cAMP, and Ins(1,4,5)P3 levels were determined: 0,
control cells (1A3); *, cAR1-null cells (0 280). Data are means+ S.E.M. of 3 independent
experiments in triplicate.
Cells with a disruption of the GO3 gene show a normal
decrease in Ins(1,4,5)P3 levels in response to 3'NH-cAMP (results
not shown), indicating that Ga3 does not mediate inhibition of
phospholipase C. The Ga2-null cell line was not tested with 3'-
NH-cAMP, since this cell line is comparable with thefgdA strain
HC-85, which revealed that Ga2 is the stimulatory G-protein.
Figure 3 shows the effect of 3'NH-cAMP on the Ins(1,4,5)P3
levels in the Gal-null strain and its isogenic control cell line,
JH131 and JH130 respectively. Whereas 3'NH-cAMP induces a
decrease in Ins(1,4,5)P3 levels in control cells, the Gal-null cells
shows neither a decrease in the cellular Ins(1,4,5)P3 level in vivo
nor a decrease in phospholipase C activity in vitro in response to
3'NH-cAMP (Figure 3). Thus in the Gal -null cells the inhibitory
pathway to phospholipase C has been disrupted, which identifies
(a)
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Gal as the G-protein coupling the receptor for 3'NH-cAMP to
inhibition of phospholipase C.
In order to find the function of the surface cAMP receptor
cARl in the regulation of phospholipase C, cARl-null cells were
stimulated with 3'NH-cAMP and cAMP. The results show that
disruption ofcARl leads to the absence of 3'NH-cAMP-induced
inhibition of phospholipase C (Figure 4), whereas cAMP still
stimulates the enzyme (results not shown). Thus the receptor
coupling the inhibitory action of 3'-NH-cAMP to phospholipase
C is coded for by cARl. Since cAMP stimulation of phospho-
lipase C is unimpaired in these cells, cARl appears not to be
essential in the stimulatory pathway.
DISCUSSION
Regulation of phospholipase C has been studied extensively in
many organisms and cell types, and several reports on the
inhibition of phospholipase C are known. Basically two mech-
anisms are proposed for this inhibition: on the one hand,
phosphorylation of activating compounds through the action of
either protein kinase C, providing a negative-feedback mech-
anism, or protein kinase A, allowing cross-talk between cAMP
and Ins(1,4,5)P3 signalling [21-24]; on the one hand, a direct
inhibitory action of G-proteins. The evidence for this latter
possibility is based on indirect observations, e.g. the effect of
guanine nucleotides and NaF on the activation of phospholipase
C [25-27]. In the present paper we provide further genetic
evidence for the presence of a receptor/G-protein-mediated
inhibitory pathway for phospholipase C and identify the receptor
and G-protein involved.
Using a combined approach of pharmacological and
molecular-genetic techniques to elucidate the regulatory com-
ponents involved in the modulation of phospholipase C activity
in Dictyostelium discoideum, two regulatory pathways can be
discerned, a stimulatory pathway activated by cAMP and an
inhibitory one which is specifically activated by the analogue
3'NH-cAMP. This feature of 3'-NH-cAMP allows pharma-
cological separation of the two different pathways. It is likely
that cAMP activates both the stimulatory and the inhibitory
pathway, since the cAMP-dose-response curve of phospholipase
C stimulation is bell-shaped, with stimulation at low cAMP
concentrations and inhibition at high concentrations [35]. Using
cell lines with deletions of either specific G-protein a-subunits or
cARl, the components involved in phospholipase C regulation
were identified; the results are summarized in Table 1. cARl was
identified as the inhibitory receptor and Gocl as the inhibitory G-
protein a-subunit, since removal of either of these two proteins
through homogolous recombination resulted in the loss of 3'NH-
cAMP-mediated inhibition of phospholipase C. The stimulatory
Table 1 Summary of the regulation of phospholipase C In Dictyostelium
Key: +, stimulation; -, inhibition; 0, no effect; 0/-, slight inhibition; ND, not determined.
Phospholipase C after stimulation with
Defective



















pathway is composed of an unknown receptor and Ga2 as the a-
subunit of the stimulatory G-protein. The latter was shown by
the lack of phospholipase C activation in mutantfgdA by either
cAMP or GTP[S]. The identity of the stimulatory receptor
remains to be established. To date, four different cAMP receptors
have been identified genetically in Dictyostelium, designated
cAR -4. As shown above, cARl is the inhibitory receptor, and
cAR2 and cAR4 are not expressed in aggregation-competent
cells, which would leave only cAR3 as a possible candidate.
However, the binding specificity of cARl-3 for various cAMP
analogues is very similar, including the binding specificity for
3'NH-cAMP [38]. This implies that cAR3 would bind 3'NH-
cAMP as efficiently as cARl. Since the stimulatory receptor is
not effected by 3'NH-cAMP, involvement of cAR3 is unlikely,
which would mean that the stimulatory receptor is an unknown
cAR. It is possible that the stimulatory receptor is the product of
the fgd C gene, which is suggested by the observation that the
defect infgdC is upstream of Ga2. Final proof of this hypothesis
can only be obtained by cloning thefgd C gene. Restoration of
stimulation of phospholipase C could be used in complement-
ation assays.
Thus a model for the regulation of phospholipase C in
Dictyostelium emerges. Figure 5 is a schematic representation of
this model, in which all components, with the exception of the
stimulatory receptor, have been characterized and their respective
genes cloned, including phospholipase C [39]. During devel-
opment of wild-type cells phospholipase C is inhibited by GTP[S]
during growth and stimulated during cell aggregation [35]. This
differential regulation coincides with the expression of the
regulatory G-proteins. The inhibitory Gal is expressed through-
out development, whereas the stimulatory Ga2 only during cell
aggregation. The interaction of two different G-proteins with
phospholipase C, the simple and fast assay for phospholipase C
and the possibility to create cell lines lacking either of these G-
proteins provides a powerful tool to study the interaction between
G-proteins and phospholipase C. Using chimeras of GI and G2,
the functional domains of G-proteins interacting with phospho-
lipase C can be determined.
In most eukaryotic cells one hormone activates multiple
effector enzymes. Specificity of signal transduction is generally
provided by the effector enzyme being activated by a specific G-
protein and sometimes by a specific receptor. The current model
for signal transduction in Dictyostelium is largely based on the
observations made withfgd A. This mutant lacks one G-protein
and is defective in nearly all sensory transduction in vivo,
including the activation of adenylate cyclase, guanylate cyclase
and phospholipase C [14,15,17]. Since GTP[S] stimulation of
adenylate and guanylate cyclases in vitro are essentially normal,
and GTP[S] stimulation of phospholipase C is absent, a hierarchy
of signal transduction was proposed, with G2 and its effector
(possibly phospholipase C) at the heart and adenylate and
guanylate cyclases downstream. The present results are probably
not in accordance with such a model. The defect of mutant fgd
C for the activation of phospholipase C is upstream of G2.
Whereas the fgd A gene product Ga2 is essential for nearly all
signal transduction, the fgd C gene product is not required for
the activation of adenylate and guanylate cyclases [14,16]. These
considerations suggest several parallel signal-transduction routes
in Dictyostelium, in which G2 is essential for the coupling of the
stimulatory receptors to the different effectors. Specificity of
signal transduction may be provided by three non-exclusive
mechanisms: (i) different receptors, (ii) other G-proteins, and
(iii) other intracellular proteins. Arguments for each of these
models are available. Receptor: if the fgd C gene product is a
receptor, as tentatively suggested in the present paper, then this
Regulation of phospholipase C in Dictyostelium 193
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Figure 5 Model for the regulation of phospholipase C
Mutants and known genes are indicated by boxes. DdPLC is the Dictyostelium PLC gene [39].
The identities of the stimulatory receptor Rs and fgd C are unknown. The fgd C gene product
functions upstream of the G-protein G2. Abbreviations used: RS' stimulatory receptor; Rj,
inhibitory receptor; Gps, stimulatory G-protein; Gp,, inhibitory G-protein.
receptor is not involved in the activation of adenylate and
guanylate cyclases [16]. G-protein: cAMP-mediated stimulation
of adenylate cyclase is absent in G2-null cells; however, GTP[S]-
mediated stimulation of this enzyme is normal in membranes,
indicating that, besides G2, another G-protein is required for
stimulation of adenylate cyclase [15]. Other proteins: different
cytosolic proteins are essential for the optimal activity of
adenylate cyclase [7,40] and guanylate cyclase [41]; these
associated proteins could be involved in the routing of the cAMP
signal from one receptor or G-protein to the different effector
enzymes.
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